Navigation Links
Cynosure Appoints H. Travis Lee as Vice President of Global Marketing
Date:5/14/2008

WESTFORD, Mass., May 14 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced the appointment of H. Travis Lee as vice president of global marketing. Lee will develop and implement worldwide strategic marketing initiatives for all of Cynosure's flagship products, including the Smartlipo MPX, the company's newest system for laser lipolysis, which will debut internationally in the second half of this year.

"As a global marketing executive, Travis has produced outstanding results in a career that spans more than two decades and includes two of the medical device industry's leading companies -- Smith & Nephew and Boston Scientific," said Cynosure President and Chief Executive Officer Michael Davin. "Colleagues and co-workers praise his ability to articulate brand value, cultivate strong relationships with key opinion leaders and identify new business opportunities."

Lee joined Cynosure from the global medical technology company Smith & Nephew Inc., where he served as global director of marketing for the endoscopy division, with responsibility for two franchises that accounted for more than $300 million in revenue. In addition to building and leading the department, he developed key opinion leaders and integrated them into the division's product development process, and led the efforts behind two significant acquisition targets.

Prior to that he worked for more than five years at Boston Scientific Corp., a manufacturer of products for minimally invasive surgical procedures, first as principal product manager in the urology/gynecology division and then as group product manager in the neurovascular division. In this role he had global responsibility for a product line with 70% worldwide market share.

In addition, Lee has worked in executive marketing positions for companies including Cell Robotics, Inc., Medasonics, Inc., Xintec Corp. and Heraeus Surgical Inc., which was later acquired by Laserscope. Among his accomplishments at Heraeus Surgical, Lee managed the investigation, implementation and launch of a new CO2 laser system for cosmetic applications that generated more than $10 million in sales in less than six months. He also successfully launched four new capital laser equipment products and more than 10 new disposable and reusable laser accessories in his first year.

"Cynosure has built an international reputation for technology innovation and product excellence," Lee said. "With the international launch of the Smartlipo MPX scheduled for the second half of this year, this is a particularly exciting time to join the company. I look forward to leading the marketing team as we focus on continuing the success that has established Cynosure as the fastest-growing company in the aesthetic industry."

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com.

Safe Harbor

Any statements in this press release about future expectations, plans and prospects for Cynosure, Inc., including statements about the company's expectations and future financial performance, as well as other statements containing the words "believes," "anticipates," "plans," "expects," "will" and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including Cynosure's reliance on sole source suppliers, the inability to accurately predict the timing or outcome of regulatory decisions, changes in consumer preferences, competition in the aesthetic laser industry, economic, market, technological and other factors discussed in Cynosure's most recent Annual Report on Form 10-K, which is filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, while Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.


'/>"/>
SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
2. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
3. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
4. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
5. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
6. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
7. Biopure Appoints Dechra Exclusive U.S. Distributor of Oxyglobin
8. Angiotech appoints Hank McKinnell to its Board of Directors
9. Adnavance Technologies Inc. Appoints Christian P. Valcke, Ph.D., to Its Scientific Advisory Board
10. Verenium Appoints John F. Dee to Board of Directors
11. Cytochroma Appoints R. Richard Wieland II As CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division ... tuned and optimized exclusively for Okuma CNC machining centers at The International Manufacturing ... collaboration among several companies with expertise in toolholding, cutting tools, machining dynamics and ...
(Date:6/23/2016)... 2016 ReportsnReports.com adds 2016 ... its pharmaceuticals section with historic and forecast data ... more. Complete report on the Cell ... 15 companies and supported with 261 tables and ... . The Global Cell Culture Media ...
Breaking Biology Technology:
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):